J. Ruckdeschel

A. Wozniak, A. Turrisi, S. Gadgeel, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multicenter phase II study of brequinar sodium in patients with advanced lung cancer

J. Ruckdeschel, J. Maroun, R. Morgan, 2004, Cancer Chemotherapy and Pharmacology.

Lung cancer in patients seropositive for human immunodeficiency virus.

S. Remick, J. Ruckdeschel, M. Braun, 1990, Radiology.

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

D. Finkelstein, J. Ruckdeschel, B. Mason, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

G. Bepler, A. Cantor, E. Haura, 2003, Cancer control : journal of the Moffitt Cancer Center.

Gefitinib ( ZD 1839 ) in Previously Treated Advanced Non – Small-Cell Lung Cancer : Experience From a Single Institution

G. Bepler, A. Cantor, E. Haura, 2003 .

Whither screening for lung cancer?

J. Ruckdeschel, 1988, Journal of the National Cancer Institute.

Chemotherapy of metastatic non‐small cell carcinoma of the lung

J. Ruckdeschel, 1992, Hematological oncology.

Is chemotherapy for metastatic non-small cell lung cancer "worth it"?

J. Ruckdeschel, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An allelic variant at the ATM locus is implicated in breast cancer susceptibility.

K. Lunetta, D. Neuberg, R. Gatti, 1997, Genetic testing.

Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment.

M. Mckneally, J. Ruckdeschel, A. Stranahan, 1972, The New England journal of medicine.

Noninvasive evaluation of mediastinal metastases in bronchogenic carcinoma: A prospective comparison of chest radiography and gallium‐67 scanning

M. Mckneally, J. Horton, J. Ruckdeschel, 1981, Cancer.

Treatment of non-small-cell lung cancer.

J. Mulshine, E. Glatstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.

A. Wozniak, L. Krug, J. Bauman, 2014, Lung cancer.

A randomized phase II study of m‐AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non‐small cell broncliogenic carcinoma: An Eastern Cooperative Group Study

R. Day, D. Ettinger, J. Ruckdeschel, 1983, American Journal of Clinical Oncology.

Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome.

S. Remick, J. Ruckdeschel, 1992, Medical and pediatric oncology.

Celecoxib (CEL) and weekly docetaxel (DOC) in elderly or PS2 patients (pts) with advanced non-small cell lung cancer (NSCLC).

A. Wozniak, R. Parchment, S. Gadgeel, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Etoposide in the management of non‐small cell lung cancer

J. Ruckdeschel, 1991, Cancer.

A Pilot Study of the Functional Living Index‐Cancer (FLIC) Scale for the Assessment of Quality of Life for Metastatic Lung Cancer Patients: An Eastern Cooperative Oncology Group Study

D. Finkelstein, J. Wolter, B. Cassileth, 1988, American journal of clinical oncology.

A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma

J. Wolter, J. Ruckdeschel, J. Arseneau, 2004, Investigational New Drugs.

Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer.

M. Hussain, J. Ruckdeschel, M. Zimmerman, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen.

M. Mardiney, J. Ruckdeschel, K. D. Graziano, 1975, Cellular immunology.

Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity.

M. Mckneally, J. Horton, J. Ruckdeschel, 1979, International journal of radiation oncology, biology, physics.

Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola).

M. Mardiney, J. Ruckdeschel, K. D. Graziano, 1975, Cellular immunology.

Lung tumor resection does not affect debrisoquine metabolism.

R. Hoover, H. Issaq, J. Nesbitt, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.

S. Remick, J. Horton, J. Ruckdeschel, 1996, American journal of clinical oncology.

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

G. Lyman, H. Lazarus, J. Ruckdeschel, 1991, Cancer.

Early detection and treatment of spinal epidural metastases: The role of myelography

J. Ruckdeschel, L. Rodichok, L. Prevosti, 1986, Annals of neurology.

Primary Central Nervous System Lymphoma in Patients with and without the Acquired Immune Deficiency Syndrome: A Retrospective Analysis and Review of the Literature

R. Haase, S. Remick, J. Ruckdeschel, 1990, Medicine.

Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease.

M. Mardiney, J. Ruckdeschel, S. Schimpff, 1977, The American journal of medicine.

Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma.

S. Remick, J. Horton, J. Ruckdeschel, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re-Analysis of in Vitro Lymphocyte Blastogenesis Using the Laser Cytometry Assay

J. Ruckdeschel, M. Miani, L. Lininger, 1979 .

Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.

J. Ruckdeschel, P. Wiernik, S. Schimpff, 1977, Cancer treatment reports.

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

D. Ettinger, D. Finkelstein, D. Trump, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.

Guillermo E. Rivas, R. Elston, D. Neuberg, 2005, Cancer research.

Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced non-small cell bronchogenic carcinoma

N. Sedransk, M. Mckneally, J. Horton, 1981, Cancer Immunology, Immunotherapy.

Vascular access for cancer chemotherapy.

J. Horton, J. Ruckdeschel, T. Cunningham, 1977, Cancer.

Vascular access for cancer chemotherapy

J. Horton, J. Ruckdeschel, T. Cunningham, 1979, JAMA.

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

D. Finkelstein, R. Hahn, D. Tormey, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).

R. Day, J. Ruckdeschel, R. Creech, 1984, Cancer treatment reports.

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.

J. Ruckdeschel, C. Mehta, R. Creech, 1981, Cancer treatment reports.

Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.

J. Horton, J. Ruckdeschel, A. Spiers, 2009, Scandinavian journal of haematology.

Quality-of-Life–Adjusted Survival Analysis of High-Dose Adjuvant Interferon Alfa-2b for High-Risk Melanoma Patients Using Intergroup Clinical Trial Data

J. Kirkwood, F. Haluska, J. Weeks, 2002 .

High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study.

M. Oken, E. Borden, D. Trump, 1987, Cancer treatment reports.

A phase II trial of CI-921 in advanced malignancies

N. Robert, J. Doroshow, L. Panasci, 1992, Investigational New Drugs.

Pemetrexed and cisplatin with concurrent thoracic radiation therapy (TRT) followed by docetaxel in stage III non-small cell lung cancer (NSCLC) patients (pts)

A. Wozniak, A. Turrisi, S. Gadgeel, 2008 .

Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.

J. Horton, J. Ruckdeschel, S. Hillinger, 1979, Cancer treatment reports.

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.

D. Ettinger, D. Neuberg, A. Wolff, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

W. McCaskill-Stevens, S. Lippman, F. Khuri, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second primary lung cancers: Analysis of E5597 selenium chemoprevention study.

F. Khuri, S. Ramalingam, J. Ruckdeschel, 2014 .

Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer

A. Wozniak, S. Gadgeel, G. Kalemkerian, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metastatic breast cancer in a young patient seropositive for human immunodeficiency virus.

S. Remick, J. Ruckdeschel, J. McSharry, 1991, Journal of the National Cancer Institute.

Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group.

M. Gail, R. Ginsberg, S. Piantadosi, 1988, The Journal of thoracic and cardiovascular surgery.

Use of posttreatment imaging and biomarkers in survivors of early‐stage breast cancer: Inappropriate surveillance or necessary care?

M. Gould, Corrine E. Munoz-Plaza, J. Ruckdeschel, 2016, Cancer.

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What are the benefits and harms of adjuvant chemotherapy in people with resected early-stage non-small cell lung cancer?

J. Ruckdeschel, S. Tort, 2018, Cochrane Clinical Answers.

Therapeutic options for the treatment of small cell and non‐small cell lung cancer

J. Ruckdeschel, 1993, Current opinion in oncology.

Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.

M. Gould, Corrine E. Munoz-Plaza, J. Ruckdeschel, 2015, Journal of oncology practice.

Unstructured Data Are Superior to Structured Data for Eliciting Quantitative Smoking History From the Electronic Health Record.

J. Ruckdeschel, Mark Riley, Sriram Parsatharathy, 2023, JCO clinical cancer informatics.

Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung.

M. Mckneally, J. Horton, J. Ruckdeschel, 1985, Cancer treatment reports.

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).

D. Ettinger, D. Tritchler, J. Ruckdeschel, 1984, Cancer treatment reports.

Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinum Refractory Non-small Cell Lung Cancer (NSCLC)

A. Wozniak, E. Heath, S. Gadgeel, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cediranib, a VEGF receptor 1, 2, and 3 inhibitor, and pemetrexed in patients (pts) with recurrent non-small cell lung cancer (NSCLC).

A. Wozniak, M. Edelman, S. Gadgeel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.

M. Cohen, J. Ruckdeschel, H. Lerner, 1981, Cancer treatment reports.

The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen.

M. Mardiney, J. Ruckdeschel, 1976, Journal of immunological methods.

The clinical significance of variant-morphology small-cell carcinoma of the lung.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.

A. Wozniak, S. Gadgeel, G. Kalemkerian, 2010, Clinical lung cancer.

BIO22-029: Identification of Patients Eligible for Lung Cancer Screening by Natural Language Processing

J. Ruckdeschel, Chiny Driscoll, Sriram Parasarathy, 2022, Journal of the National Comprehensive Cancer Network.

Quality of life in lung cancer surgical adjuvant trials.

S. Piantadosi, J. Ruckdeschel, J. Ruckdeschel, 1994, Chest.

Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).

D. Ettinger, J. Ruckdeschel, S. Phan, 2000, The cancer journal from Scientific American.

A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).

G. Goodman, G. Clamon, J. Ruckdeschel, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Dose‐dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small‐cell Lung Cancer

A. Wozniak, S. Gadgeel, G. Kalemkerian, 2017, Clinical lung cancer.

Role of Ubiquitin-proteasome proteolytic pathway in malignant pleural mesothelioma.

Zhandong Liu, H. Pass, Q. Dou, 2007 .

Management of malignant pleural effusion: an overview.

J. Ruckdeschel, J. Ruckdeschel, 1988, Seminars in oncology.

A white blood cell RNase assay for the possible monitoring of malignancy.

C. Levy, M. Mardiney, J. Ruckdeschel, 1975, Journal of the National Cancer Institute.

Cediranib, a VEGF receptor 1, 2, and 3 inhibitor, and pemetrexed in patients (pts) with recurrent non-small cell lung cancer (NSCLC).

A. Wozniak, M. Edelman, A. Shields, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic Adenoid Cystic Carcinoma of Salivary Glands: Case Reports and Review of the Literature.

Horton, D. Esseltine, J. Ruckdeschel, 1996, Cancer control : journal of the Moffitt Cancer Center.

In vitro chemosensitivity of human lung cancer cell lines.

A. Gazdar, E. Russell, D. Carney, 1987, Cancer treatment reports.

Automated fluorescent analysis for drug-induced cytotoxicity assays.

A. Gazdar, P. Bunn, J. Ruckdeschel, 1986, Cancer treatment reports.

Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881.

S. Piantadosi, J. Ruckdeschel, H. Wagner, 1994, Chest.

Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.

D. Ettinger, D. Finkelstein, J. Wolter, 1985, Cancer treatment reports.

Radiation-related pericarditis.

J. Ruckdeschel, R. Byhardt, J. Ruckdeschel, 1975, The American journal of cardiology.

Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy: Overview of Four Clinical Trials

A. Sampson, G. Beall, M. Gottlieb, 1992 .

Fibrinogen catabolism in rats fed thrombogenic diets.

T. Peters, J. Ruckdeschel, J. Ruckdeschel, 1972, Atherosclerosis.

Use of posttreatment imaging and biomarkers in survivors of early‐stage breast cancer: Inappropriate surveillance or necessary care?

M. Gould, Corrine E. Munoz-Plaza, J. Ruckdeschel, 2016, Cancer.

Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.

J. Kirkwood, F. Haluska, J. Weeks, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.